Recent
price
P/E
ratio
div
yld
- -
ROIC.AI
Halozyme Therapeutics (HALO) is an Incredible Growth Stock: 3 Reasons Why
Halozyme Therapeutics (HALO) is an Incredible Growth Stock: 3 Reasons Why
Halozyme Therapeutics (HALO) Upgraded to Buy: Here's What You Should Know
Halozyme Therapeutics (HALO) Upgraded to Buy: Here's What You Should Know
Analysts Offer Insights on Healthcare Companies: Ocular Therapeutix (OCUL), Marinus (MRNS) and Halozyme (HALO)
Analysts Offer Insights on Healthcare Companies: Halozyme (HALO) and MacroGenics (MGNX)
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
Halozyme Therapeutics (HALO) is a Top-Ranked Value Stock: Should You Buy?
Halozyme Therapeutics (HALO) is a Top-Ranked Value Stock: Should You Buy?
Is Now The Time To Put Halozyme Therapeutics (NASDAQ:HALO) On Your Watchlist?
Mirum Pharmaceuticals (MIRM) Down 12.5% Since Last Earnings Report: Can It Rebound?
Mirum Pharmaceuticals (MIRM) Down 12.5% Since Last Earnings Report: Can It Rebound?
The 3 Best Biotech Stocks to Buy in Q2 2024
Why Is Denali Therapeutics (DNLI) Up 2.8% Since Last Earnings Report?
Why Is Denali Therapeutics (DNLI) Up 2.8% Since Last Earnings Report?
Fate Therapeutics (FATE) Down 8% Since Last Earnings Report: Can It Rebound?
Why Is Halozyme Therapeutics (HALO) Up 5.3% Since Last Earnings Report?
Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio
Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio
•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.